See All Slides -

Slides

Presentation TCT 2016

Intermediate-Risk Studies I: Synthesis of the PARTNER 2A and the Sapien 3 Intermediate-Risk Trials

Presenter: Patrick T. O'Gara, Alec S. Vahanian, Susheel K. Kodali

October 30, 2016

Presentation TCT 2016

Outcomes and Role of Ablation in the Treatment Approach to Atrial Fibrillation

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt, Vivek Y. Reddy

October 30, 2016

Presentation TCT 2016

Quality-of-Life Measures as Valid Clinical Surrogates and Primary Endpoints in Randomized Trials: Why the Resistance?

Presenter: Roxana Mehran, Pascal Vranckx, John A. Spertus

October 30, 2016

Presentation TCT 2016

Stent Design and Comprehensive Data Review: From Nobori to Ultimaster Biolimus-Eluting Stents

Presenter: Dean J. Kereiakes, Pieter C. Smits, Shigeru Saito

October 30, 2016

Presentation TCT 2016

Technical Uncertainties 2: Kiss, POT, and RePOT - When and How?

Presenter: Antonio Colombo, Thierry Lefevre, Ioannis Iakovou

October 30, 2016

Presentation TCT 2016

Management of Complications From Aortoiliac Intervention

Presenter: D. Christopher Metzger, Constantino S. Pena

October 30, 2016

Presentation TCT 2016

Anatomical Variants and Their Impact on Radial Success

Presenter: Francesco Burzotta, Sunil V. Rao

October 30, 2016

Presentation TCT 2016

BVS in Primary PCI Using A Robotic Cath Lab System

Presenter: Habib Gamra, Mahmoud Hashemian, Abdullah Shehab, Arif Al Nooryani

October 30, 2016

Presentation TCT 2016

Real-world Requirements and Expectations for TAVR in Lower Risk Patients

Presenter: Patrick T. O'Gara, Alec S. Vahanian, Martin B. Leon

October 30, 2016

Presentation TCT 2016

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro Pacing

Presenter: Bernard J. Gersh, Harry Rakowski, Michael A. Fifer

October 30, 2016

Advertisement

Slides

Intermediate-Risk Studies I: Synthesis of the PARTNER 2A and the Sapien 3 Intermediate-Risk Trials

Outcomes and Role of Ablation in the Treatment Approach to Atrial Fibrillation

Quality-of-Life Measures as Valid Clinical Surrogates and Primary Endpoints in Randomized Trials: Why the Resistance?

Stent Design and Comprehensive Data Review: From Nobori to Ultimaster Biolimus-Eluting Stents

Technical Uncertainties 2: Kiss, POT, and RePOT - When and How?

Management of Complications From Aortoiliac Intervention

Anatomical Variants and Their Impact on Radial Success

BVS in Primary PCI Using A Robotic Cath Lab System

Real-world Requirements and Expectations for TAVR in Lower Risk Patients

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro Pacing

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content